Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells

Top Cited Papers
Open Access
Abstract
No abstract available
Funding Information
  • Beijing advanced Innovation Center for Genomics
  • Fundamental Research Funds for the Central Universities (A20ZX00846)
  • Beijing Municipal Commission of Science and Technology (Z201100005420018)
  • National Center for Protein Sciences at Peking University
  • National Mega Projects of China for Major Infectious Diseases (2017ZX10304402)
  • Development Project of China (2016YFD0500304)
  • CAMS Initiative for Innovative Medicine of China (2016-12M-2-006)